Neuromuscular Disorders
Volume 20, Issue 2 , Pages 98-101, February 2010

Ca2+ sensitizers: An emerging class of agents for counterbalancing weakness in skeletal muscle diseases?

  • Julien Ochala

      Affiliations

    • Corresponding Author InformationAddress: Department of Neuroscience, Clinical Neurophysiology, University Hospital, Entrance 85, 3rd Floor, SE-751 85 Uppsala, Sweden. Tel.: +46 18 611 9338; fax: +46 18 55 6106.

Department of Clinical Neurophysiology, Uppsala University Hospital, Sweden

Received 5 September 2009; received in revised form 14 November 2009; accepted 17 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0960-8966(09)00692-0

doi:10.1016/j.nmd.2009.11.010

Neuromuscular Disorders
Volume 20, Issue 2 , Pages 98-101, February 2010

Article Tools

* Image Usage & Resolution